Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 7/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | HSD17B3 | P37058 | 5/20 | 0.49 |
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | MLYCD | O95822 | 1/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9830934 | 0.94 | CA2 (0.69) | CA2FOLH1CA1CA12CA9 | |
| SCHEMBL9830928 | 0.94 | CA2 (0.69) | CA2FOLH1CA1CA12CA9 | |
| SCHEMBL29036089 | 0.88 | CA2 (0.61) | CA2FOLH1NOD1 | |
| SCHEMBL7759090 | 0.88 | CA2 (0.61) | CA2FOLH1NOD1 | |
| SCHEMBL3082006 | 0.88 | CA2 (0.76) | CA2FOLH1CA1CA12CA9 | |
| SCHEMBL32689107 | 0.87 | CA2 (0.61) | CA2FOLH1CA1CA12CA9 | |
| SCHEMBL24064866 | 0.87 | CA2 (0.63) | CA2FOLH1 | |
| SCHEMBL7913352 | 0.86 | CA2 (0.60) | CA2FOLH1 | |
| SCHEMBL7034241 | 0.84 | LNPEP (0.60) | CA2FOLH1CA1CA12CA9 | |
| SCHEMBL7034236 | 0.84 | LNPEP (0.60) | CA2FOLH1CA1CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | claimed |